≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

Endpoint Browser

VWXY20_OCCUPANT_HEAVY_TRANSPO_VEHIC_INJURED_OTHER_UNSPE_TRANSPO_ACCIDENTS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — V69
  • Cause of death: ICD-10 — V69

2 out of 7 registries used, show all original rules.

217

4. Check minimum number of events

None

217

5. Include endpoints

None

217

6. Filter based on genotype QC (FinnGen only)

213

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
5
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
V29|V[3-8]

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 213 31 182
Unadjusted period prevalence (%) 0.07 0.01 0.08
Median age at first event (years) 44.61 41.99 45.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
217
Matched controls
2170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
V69.9
ICD-10 Finland
Occupant [any] of heavy transport vehicle injured in unspecified traffic accident
+∞
205.2
163
*
V69.2
ICD-10 Finland
Unspecified occupant of heavy transport vehicle injured in collision with other and unspecified motor vehicles in nontraffic accident
+∞
58.0
53
*
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
8.4
24.1
34
47
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
7.5
21.1
33
51
S06.0
ICD-10 Finland
Concussion
4.2
16.1
50
143
NA1AD
NOMESCO Finland
Cervical spine CT examination
5.7
14.1
28
55
S20.2
ICD-10 Finland
Contusion of thorax
4.8
12.1
29
67
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
15.9
12.0
19
13
V69
ICD-10 Finland
Occupant of heavy transport vehicle injured in other and unspecified transport accidents
+∞
11.6
11
*
Z02.4
ICD-10 Finland
Examination for driving licence
2.6
10.0
83
417
T90.5
ICD-10 Finland
Sequelae of intracranial injury
11.4
9.5
17
16
ZXD05
NOMESCO Finland
Urgent procedure
2.5
8.8
76
386
S06.2
ICD-10 Finland
Diffuse brain injury
17.2
8.7
13
8
S22.4
ICD-10 Finland
Multiple fractures of ribs
8.4
8.6
18
23
S22.3
ICD-10 Finland
Fracture of rib
3.3
8.3
34
116
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
8.1
33
112
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
6.4
7.9
20
34
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.8
7.1
22
62
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
6.9
43
185
S01.0
ICD-10 Finland
Open wound of scalp
3.1
6.8
30
106
S22.1
ICD-10 Finland
Multiple fractures of thoracic spine
+∞
6.3
6
*
S72.3
ICD-10 Finland
Fracture of shaft of femur
27.5
6.3
8
*
XA800
NOMESCO Finland
Neuropsychological investigation
4.0
6.2
18
48
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
6.2
110
728
N02AX02
ATC
tramadol; systemic, rectal
2.0
6.0
102
661

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
General Surgery
2 [38004447]
6.2e-01
8.6e-01
2.3e+00
—
3.4e+00
1.8e+00
6.3e-01
cases:26.27%
controls:16.04%
cases:10.14%
controls:4.56%
cases:5.07%
controls:0.51%
—
—
cases:13.36%
controls:0.51%
cases:21.13%
controls:4.26%
cases:23.12%
controls:13.80%
57
348
160
1822
22
99
195
2071
11
11
206
2159
—
29
11
188
2155
45
90
168
2023
46
271
153
1693
Orthopedic Surgery
20 [38004465]
6.2e-01
8.6e-01
1.6e+00
—
3.0e+00
1.9e+00
1.2e+00
cases:17.05%
controls:9.95%
cases:8.29%
controls:3.69%
cases:4.61%
controls:0.92%
—
—
cases:12.44%
controls:0.69%
cases:22.07%
controls:4.21%
cases:31.16%
controls:12.12%
37
216
180
1954
18
80
199
2090
10
20
207
2150
—
27
15
190
2151
47
89
166
2024
62
238
137
1726
Emergency Room Visit
ER [9203]
5.9e-01
6.4e-01
2.0e+00
—
2.1e+00
8.1e-01
5.7e-01
cases:41.01%
controls:27.79%
cases:18.43%
controls:10.65%
cases:8.29%
controls:1.15%
—
—
cases:9.22%
controls:1.20%
cases:19.25%
controls:9.56%
cases:41.71%
controls:28.87%
89
603
128
1567
40
231
177
1939
18
25
199
2145
—
20
26
197
2140
41
202
172
1911
83
567
116
1397
Outpatient Visit
OP [9202]
3.1e-01
1.7e-01
2.4e-01
3.4e+00
1.2e+00
8.9e-01
6.3e-01
cases:62.21%
controls:54.65%
cases:38.71%
controls:34.70%
cases:9.22%
controls:7.42%
cases:9.22%
controls:0.32%
cases:22.12%
controls:7.76%
cases:57.28%
controls:35.49%
cases:79.90%
controls:67.92%
135
1186
82
984
84
753
133
1417
20
161
197
2009
20
7
197
2163
48
168
169
1998
122
750
91
1363
159
1334
40
630
Inpatient Hospital
21 [8717]
4.8e-01
4.3e-01
1.7e+00
—
2.3e+00
1.1e+00
8.6e-01
cases:35.48%
controls:25.39%
cases:13.36%
controls:9.08%
cases:5.53%
controls:1.11%
—
—
cases:11.06%
controls:1.25%
cases:22.54%
controls:8.85%
cases:38.19%
controls:20.77%
77
551
140
1619
29
197
188
1973
12
24
205
2146
—
24
27
193
2139
48
187
165
1926
76
408
123
1556
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.2e-01
2.1e-01
3.9e-01
4.1e+00
1.3e+00
3.7e-01
1.3e-01
cases:17.05%
controls:14.15%
cases:14.29%
controls:11.94%
cases:3.69%
controls:2.53%
cases:11.98%
controls:0.23%
cases:8.76%
controls:2.59%
cases:17.84%
controls:13.06%
cases:32.16%
controls:29.33%
37
307
180
1863
31
259
186
1911
8
55
209
2115
26
5
191
2165
19
56
198
2110
38
276
175
1837
64
576
135
1388
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.9e-01
2.0e-01
3.7e-01
4.1e+00
1.2e+00
3.4e-01
1.4e-01
cases:17.05%
controls:14.47%
cases:14.29%
controls:12.03%
cases:3.69%
controls:2.58%
cases:11.98%
controls:0.23%
cases:8.76%
controls:2.72%
cases:17.84%
controls:13.35%
cases:32.66%
controls:29.74%
37
314
180
1856
31
261
186
1909
8
56
209
2114
26
5
191
2165
19
59
198
2107
38
282
175
1831
65
584
134
1380
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.4e-01
5.5e-01
—
—
2.5e+00
1.4e+00
1.3e+00
cases:7.37%
controls:6.45%
cases:4.15%
controls:2.44%
—
—
—
—
cases:6.91%
controls:0.60%
cases:9.39%
controls:2.46%
cases:19.10%
controls:5.96%
16
140
201
2030
9
53
208
2117
—
—
15
13
202
2153
20
52
193
2061
38
117
161
1847
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.8e-01
2.6e-01
3.6e-01
3.8e+00
1.3e+00
3.6e-01
1.0e-01
cases:19.35%
controls:16.73%
cases:18.43%
controls:14.79%
cases:4.61%
controls:3.27%
cases:11.52%
controls:0.28%
cases:10.14%
controls:2.95%
cases:20.66%
controls:15.33%
cases:37.19%
controls:34.88%
42
363
175
1807
40
321
177
1849
10
71
207
2099
25
6
192
2164
22
64
195
2102
44
324
169
1789
74
685
125
1279
Laboratory Visit
OMOP4822461 [32036]
5.6e-02
4.2e-02
9.1e-02
3.9e+00
1.1e+00
1.3e-01
1.4e-02
cases:23.96%
controls:22.95%
cases:23.04%
controls:22.30%
cases:7.37%
controls:6.77%
cases:14.29%
controls:0.32%
cases:16.13%
controls:5.96%
cases:25.35%
controls:23.00%
cases:43.72%
controls:43.38%
52
498
165
1672
50
484
167
1686
16
147
201
2023
31
7
186
2163
35
129
182
2037
54
486
159
1627
87
852
112
1112
Neurology
13 [38004458]
5.8e-01
5.0e-01
—
1.0e+50
2.3e+00
1.6e+00
1.1e+00
cases:10.60%
controls:6.22%
cases:5.07%
controls:3.13%
—
—
cases:5.07%
controls:0.00%
cases:5.07%
controls:0.55%
cases:13.62%
controls:3.12%
cases:19.10%
controls:7.54%
23
135
194
2035
11
68
206
2102
—
11
0
206
2170
11
12
206
2154
29
66
184
2047
38
148
161
1816
Case Management Agency
251B00000X [38004193]
-3.7e-02
5.1e-02
2.1e-01
3.8e+00
8.2e-01
2.9e-01
2.8e-01
cases:44.70%
controls:45.62%
cases:38.25%
controls:37.05%
cases:16.59%
controls:13.82%
cases:20.74%
controls:0.60%
cases:24.42%
controls:12.47%
cases:46.48%
controls:39.28%
cases:67.84%
controls:61.51%
97
990
120
1180
83
804
134
1366
36
300
181
1870
45
13
172
2157
53
270
164
1896
99
830
114
1283
135
1208
64
756
Outpatient Hospital
22 [8756]
3.8e-01
3.3e-01
1.3e+00
1.0e+50
2.2e+00
1.3e+00
1.0e+00
cases:24.88%
controls:18.53%
cases:8.29%
controls:6.08%
cases:2.76%
controls:0.74%
cases:23.50%
controls:0.00%
cases:6.45%
controls:0.78%
cases:16.90%
controls:5.11%
cases:33.17%
controls:15.43%
54
402
163
1768
18
132
199
2038
6
16
211
2154
51
0
166
2170
14
17
203
2149
36
108
177
2005
66
303
133
1661
codeine and paracetamol
N02AJ06 [1123647]
6.4e-01
3.0e-01
1.6e+00
—
2.2e+00
9.4e-01
6.5e-01
cases:19.35%
controls:11.20%
cases:5.99%
controls:4.52%
cases:2.76%
controls:0.55%
—
—
cases:6.91%
controls:0.83%
cases:11.74%
controls:4.92%
cases:23.62%
controls:13.95%
42
243
175
1927
13
98
204
2072
6
12
211
2158
—
15
18
202
2148
25
104
188
2009
47
274
152
1690
Supplier / Service Provider
OMOP5117446 [33004]
-1.3e+00
-8.1e-01
-1.0e+50
—
—
2.0e+00
3.7e+00
cases:7.83%
controls:24.24%
cases:4.15%
controls:8.85%
cases:0.00%
controls:1.66%
—
—
—
—
cases:2.82%
controls:0.38%
cases:18.09%
controls:0.56%
17
526
200
1644
9
192
208
1978
0
36
217
2134
—
—
6
8
207
2105
36
11
163
1953
Office Visit
OMOP4822458 [581477]
4.1e-01
5.7e-01
—
—
3.1e+00
1.2e+00
5.8e-01
cases:9.68%
controls:6.64%
cases:3.23%
controls:1.84%
—
—
—
—
cases:8.76%
controls:0.42%
cases:7.98%
controls:2.46%
cases:11.56%
controls:6.82%
21
144
196
2026
7
40
210
2130
—
—
19
9
198
2157
17
52
196
2061
23
134
176
1830
General Practice
1 [38004446]
5.6e-01
8.9e-01
—
1.0e+50
2.6e+00
6.7e-01
7.3e-01
cases:15.21%
controls:9.31%
cases:9.22%
controls:4.01%
—
—
cases:12.90%
controls:0.00%
cases:5.53%
controls:0.42%
cases:7.04%
controls:3.74%
cases:18.09%
controls:9.62%
33
202
184
1968
20
87
197
2083
—
28
0
189
2170
12
9
205
2157
15
79
198
2034
36
189
163
1775
Emergency Medicine
93 [38004510]
7.2e-01
7.9e-01
1.6e+00
1.0e+50
2.3e+00
1.0e+00
6.9e-01
cases:11.52%
controls:5.94%
cases:7.37%
controls:3.50%
cases:2.30%
controls:0.46%
cases:18.89%
controls:0.00%
cases:4.61%
controls:0.46%
cases:9.86%
controls:3.79%
cases:24.12%
controls:13.80%
25
129
192
2041
16
76
201
2094
5
10
212
2160
41
0
176
2170
10
10
207
2156
21
80
192
2033
48
271
151
1693
ibuprofen
R02AX02 [1588667]
1.2e-02
2.2e-01
1.0e+00
—
2.3e+00
7.5e-01
7.5e-01
cases:33.18%
controls:32.90%
cases:17.05%
controls:14.15%
cases:5.53%
controls:2.03%
—
—
cases:14.75%
controls:1.71%
cases:26.29%
controls:14.43%
cases:53.77%
controls:35.54%
72
714
145
1456
37
307
180
1863
12
44
205
2126
—
32
37
185
2129
56
305
157
1808
107
698
92
1266
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
1.2e-02
2.2e-01
1.0e+00
—
2.3e+00
7.5e-01
7.5e-01
cases:33.18%
controls:32.90%
cases:17.05%
controls:14.15%
cases:5.53%
controls:2.03%
—
—
cases:14.75%
controls:1.71%
cases:26.29%
controls:14.43%
cases:53.77%
controls:35.54%
72
714
145
1456
37
307
180
1863
12
44
205
2126
—
32
37
185
2129
56
305
157
1808
107
698
92
1266
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
3.1e-01
4.1e-01
4.9e-01
—
2.2e+00
8.3e-01
6.4e-01
cases:24.88%
controls:19.59%
cases:14.75%
controls:10.28%
cases:2.76%
controls:1.71%
—
—
cases:11.52%
controls:1.39%
cases:20.19%
controls:9.89%
cases:40.70%
controls:26.63%
54
425
163
1745
32
223
185
1947
6
37
211
2133
—
25
30
192
2136
43
209
170
1904
81
523
118
1441
Exposure to unspecified factor
X59 [45756412]
6.7e-01
1.6e+00
—
—
—
2.2e+00
1.4e+00
cases:4.15%
controls:2.17%
cases:2.76%
controls:0.55%
—
—
—
—
—
—
cases:4.69%
controls:0.57%
cases:9.05%
controls:2.49%
9
47
208
2123
6
12
211
2158
—
—
—
10
12
203
2101
18
49
181
1915
Exposure to other specified factors
X58 [45756411]
3.4e-01
—
—
—
—
2.2e+00
1.2e+00
cases:2.76%
controls:1.98%
—
—
—
—
—
—
—
—
cases:4.69%
controls:0.57%
cases:7.04%
controls:2.29%
6
43
211
2127
—
—
—
—
10
12
203
2101
14
45
185
1919
Neurosurgery
14 [38004459]
1.2e+00
—
—
1.0e+50
—
2.0e+00
1.2e+00
cases:4.15%
controls:1.29%
—
—
—
—
cases:3.23%
controls:0.00%
—
—
cases:4.23%
controls:0.57%
cases:6.03%
controls:1.83%
9
28
208
2142
—
—
7
0
210
2170
—
9
12
204
2101
12
36
187
1928
Physical Medicine And Rehabilitation
25 [38004468]
2.3e-01
8.8e-01
—
—
—
1.8e+00
1.2e+00
cases:5.07%
controls:4.06%
cases:3.69%
controls:1.57%
—
—
—
—
—
—
cases:7.98%
controls:1.47%
cases:15.58%
controls:5.30%
11
88
206
2082
8
34
209
2136
—
—
—
17
31
196
2082
31
104
168
1860
Car occupant [any] injured in unspecified traffic accident
V49.9 [45566025]
—
—
—
1.0e+50
1.0e+50
—
2.9e+00
—
—
—
—
—
—
cases:2.76%
controls:0.00%
cases:5.07%
controls:0.00%
—
—
cases:6.03%
controls:0.36%
—
—
—
6
0
211
2170
11
0
206
2166
—
12
7
187
1957
Psychologist
Z2445 [2001311558]
-1.0e+50
—
—
—
—
—
2.8e+00
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.25%
0
10
217
2160
—
—
—
—
—
8
5
191
1959
Sprain and strain of shoulder joint
S43.4 [45607418]
-1.0e+50
—
—
—
—
—
2.5e+00
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.25%
0
5
217
2165
—
—
—
—
—
6
5
193
1959
Pharmacy visit
OMOP4822462 [581458]
3.9e-01
3.0e-01
1.1e-01
1.7e+00
7.9e-01
3.2e-01
3.6e-01
cases:92.63%
controls:89.45%
cases:77.88%
controls:72.30%
cases:34.56%
controls:32.03%
cases:5.99%
controls:1.20%
cases:51.15%
controls:32.13%
cases:78.87%
controls:73.02%
cases:93.97%
controls:91.55%
201
1941
16
229
169
1569
48
601
75
695
142
1475
13
26
204
2144
111
696
106
1470
168
1543
45
570
187
1798
12
166
Laceration/cut
S18 [2002000983]
4.2e-01
7.4e-01
—
—
—
1.5e+00
8.2e-01
cases:5.53%
controls:3.69%
cases:3.23%
controls:1.57%
—
—
—
—
—
—
cases:5.16%
controls:1.18%
cases:12.56%
controls:5.96%
12
80
205
2090
7
34
210
2136
—
—
—
11
25
202
2088
25
117
174
1847
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.5e-01
3.0e-01
6.5e-01
—
1.6e+00
7.2e-01
2.2e-01
cases:17.51%
controls:13.00%
cases:12.90%
controls:9.91%
cases:3.23%
controls:1.71%
—
—
cases:7.37%
controls:1.57%
cases:16.90%
controls:8.99%
cases:30.65%
controls:26.27%
38
282
179
1888
28
215
189
1955
7
37
210
2133
—
16
34
201
2132
36
190
177
1923
61
516
138
1448
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
3.5e-01
3.2e-02
—
—
2.3e+00
2.4e-01
3.1e-01
cases:18.43%
controls:13.78%
cases:4.61%
controls:4.47%
—
—
—
—
cases:2.76%
controls:0.28%
cases:5.16%
controls:4.12%
cases:17.09%
controls:13.14%
40
299
177
1871
10
97
207
2073
—
—
6
6
211
2160
11
87
202
2026
34
258
165
1706
Neuropsychological investigation
XA800 [2001300412]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.31%
—
—
—
—
—
—
6
6
193
1958
Leukocytes [Presence] in Urine
33052-2 [3045414]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.31%
—
—
—
—
—
—
6
6
193
1958
12 lead EKG panel
34534-8 [3044889]
-1.4e-01
-2.1e-01
—
—
2.2e+00
-1.6e-01
2.5e-01
cases:6.91%
controls:7.88%
cases:3.69%
controls:4.52%
—
—
—
—
cases:2.76%
controls:0.32%
cases:4.23%
controls:4.92%
cases:19.10%
controls:15.53%
15
171
202
1999
8
98
209
2072
—
—
6
7
211
2159
9
104
204
2009
38
305
161
1659
pH of Specimen
17433-4 [3019225]
—
—
—
—
—
2.2e+00
1.0e+00
—
—
—
—
—
—
—
—
—
—
cases:2.82%
controls:0.33%
cases:2.51%
controls:0.92%
—
—
—
—
—
6
7
207
2106
5
18
194
1946
Sprain and strain of cervical spine
S13.4 [45573197]
—
—
—
1.0e+50
—
—
2.2e+00
—
—
—
—
—
—
cases:6.45%
controls:0.00%
—
—
—
—
cases:3.02%
controls:0.36%
—
—
—
14
0
203
2170
—
—
6
7
193
1957
Custom moulded splint, unspecified region
TNX32 [2001308563]
-1.0e+50
—
—
—
—
—
2.0e+00
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:3.52%
controls:0.51%
0
6
217
2164
—
—
—
—
—
7
10
192
1954
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.61%
—
—
—
—
—
—
8
12
191
1952
Derangement of meniscus due to old tear or injury
M23.2 [45591779]
1.9e+00
-1.0e+50
—
—
—
-1.0e+50
—
cases:4.15%
controls:0.65%
cases:0.00%
controls:0.32%
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
9
14
208
2156
0
7
217
2163
—
—
—
0
7
213
2106
—
Contusion of other parts of wrist and hand
S60.2 [45602941]
1.9e+00
—
—
—
—
—
—
cases:3.23%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
—
—
7
11
210
2159
—
—
—
—
—
—
Abdominal ultrasound examination
JN3AE [2001305555]
—
—
—
1.0e+50
—
—
1.8e+00
—
—
—
—
—
—
cases:3.23%
controls:0.00%
—
—
—
—
cases:4.02%
controls:0.66%
—
—
—
7
0
210
2170
—
—
8
13
191
1951
Other primary coxarthrosis
M16.1 [45591741]
—
-1.0e+50
—
—
—
-1.0e+50
1.8e+00
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
cases:0.00%
controls:0.24%
cases:4.02%
controls:0.66%
—
0
5
217
2165
—
—
—
0
5
213
2108
8
13
191
1951
CBC panel - Blood by Automated count
58410-2 [40761511]
-7.3e-02
9.5e-02
3.2e-01
—
1.7e+00
2.3e-01
7.0e-02
cases:15.21%
controls:16.18%
cases:11.98%
controls:11.01%
cases:2.76%
controls:2.03%
—
—
cases:8.76%
controls:1.66%
cases:14.55%
controls:11.93%
cases:31.16%
controls:29.68%
33
351
184
1819
26
239
191
1931
6
44
211
2126
—
19
36
198
2130
31
252
182
1861
62
583
137
1381
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
3.7e-01
—
-1.0e+50
—
-1.0e+50
1.6e+00
5.1e-01
cases:3.23%
controls:2.26%
—
—
cases:0.00%
controls:0.28%
—
—
cases:0.00%
controls:0.23%
cases:6.10%
controls:1.28%
cases:7.04%
controls:4.33%
7
49
210
2121
—
0
6
217
2164
—
0
5
217
2161
13
27
200
2086
14
85
185
1879
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
S46.0 [45544769]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.03%
controls:1.07%
—
—
—
—
—
—
10
21
189
1943
Respiratory and circulatory monitoring
WX700 [2001310817]
1.2e+00
—
—
1.0e+50
—
—
1.5e+00
cases:2.76%
controls:0.83%
—
—
—
—
cases:6.91%
controls:0.00%
—
—
—
—
cases:5.03%
controls:1.12%
6
18
211
2152
—
—
15
0
202
2170
—
—
10
22
189
1942
Teaching
WZC30 [2001310891]
—
-1.0e+50
—
—
—
—
1.5e+00
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
cases:5.03%
controls:1.12%
—
0
10
217
2160
—
—
—
—
10
22
189
1942
oxycodone and naloxone; oral
N02AA55 [21604265]
1.0e+00
—
—
—
—
—
1.5e+00
cases:2.30%
controls:0.83%
—
—
—
—
—
—
—
—
—
—
cases:6.03%
controls:1.37%
5
18
212
2152
—
—
—
—
—
12
27
187
1937
Leukocytes [#/volume] in Urine
30405-5 [3018095]
3.9e-01
3.9e-01
-1.0e+50
—
-1.0e+50
1.5e+00
3.7e-01
cases:3.69%
controls:2.53%
cases:2.30%
controls:1.57%
cases:0.00%
controls:0.32%
—
—
cases:0.00%
controls:0.28%
cases:6.57%
controls:1.56%
cases:7.04%
controls:4.99%
8
55
209
2115
5
34
212
2136
0
7
217
2163
—
0
6
217
2160
14
33
199
2080
14
98
185
1866
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.9e-01
—
-1.0e+50
—
—
1.5e+00
3.6e-01
cases:2.76%
controls:1.89%
—
—
cases:0.00%
controls:0.28%
—
—
—
—
cases:4.23%
controls:0.99%
cases:5.03%
controls:3.56%
6
41
211
2129
—
0
6
217
2164
—
—
9
21
204
2092
10
70
189
1894
temazepam; oral
N05CD07 [21604642]
—
—
—
—
-1.0e+50
1.4e+00
1.5e+00
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
cases:3.29%
controls:0.85%
cases:7.54%
controls:1.83%
—
—
—
—
0
5
217
2161
7
18
206
2095
15
36
184
1928
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
—
-1.0e+50
-1.0e+50
—
—
1.3e+00
1.5e+00
—
—
cases:0.00%
controls:0.60%
cases:0.00%
controls:0.23%
—
—
—
—
cases:2.35%
controls:0.66%
cases:5.53%
controls:1.32%
—
0
13
217
2157
0
5
217
2165
—
—
5
14
208
2099
11
26
188
1938
Thorax X-ray examination
GD1AA [2001303617]
-5.1e-02
2.0e-01
—
1.0e+50
—
1.5e+00
7.7e-01
cases:4.61%
controls:4.84%
cases:2.30%
controls:1.89%
—
—
cases:3.23%
controls:0.00%
—
—
cases:5.63%
controls:1.37%
cases:11.56%
controls:5.70%
10
105
207
2065
5
41
212
2129
—
7
0
210
2170
—
12
29
201
2084
23
112
176
1852
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.5e-01
—
—
1.0e+50
—
1.4e+00
3.4e-01
cases:3.23%
controls:2.53%
—
—
—
—
cases:2.76%
controls:0.00%
—
—
cases:6.10%
controls:1.51%
cases:7.54%
controls:5.50%
7
55
210
2115
—
—
6
0
211
2170
—
13
32
200
2081
15
108
184
1856
Bacteria identified in Isolate by Culture
43409-2 [3042936]
—
—
—
—
—
1.7e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:2.35%
controls:0.43%
cases:6.03%
controls:1.53%
—
—
—
—
—
5
9
208
2104
12
30
187
1934
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-1.3e-01
1.9e-01
—
—
1.4e+00
2.2e-01
-4.0e-02
cases:10.60%
controls:11.89%
cases:11.52%
controls:9.68%
—
—
—
—
cases:7.37%
controls:1.89%
cases:11.74%
controls:9.61%
cases:23.12%
controls:23.83%
23
258
194
1912
25
210
192
1960
—
—
16
41
201
2125
25
203
188
1910
46
468
153
1496
duloxetine; oral
N06AX21 [21604749]
—
-1.0e+50
—
—
-1.0e+50
—
1.4e+00
—
—
cases:0.00%
controls:0.60%
—
—
—
—
cases:0.00%
controls:0.32%
—
—
cases:5.53%
controls:1.43%
—
0
13
217
2157
—
—
0
7
217
2159
—
11
28
188
1936
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
6.1e-02
1.9e-01
2.3e-01
—
1.3e+00
3.2e-01
8.3e-02
cases:20.28%
controls:19.31%
cases:19.35%
controls:16.59%
cases:4.61%
controls:3.69%
—
—
cases:10.60%
controls:3.14%
cases:21.60%
controls:16.66%
cases:39.70%
controls:37.73%
44
419
173
1751
42
360
175
1810
10
80
207
2090
—
23
68
194
2098
46
352
167
1761
79
741
120
1223
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
6.1e-02
1.9e-01
2.3e-01
—
1.3e+00
3.2e-01
8.7e-02
cases:20.28%
controls:19.31%
cases:19.35%
controls:16.54%
cases:4.61%
controls:3.69%
—
—
cases:10.60%
controls:3.14%
cases:21.60%
controls:16.66%
cases:39.70%
controls:37.63%
44
419
173
1751
42
359
175
1811
10
80
207
2090
—
23
68
194
2098
46
352
167
1761
79
739
120
1225
Platelets [#/volume] in Blood
26515-7 [3007461]
6.1e-02
1.9e-01
2.3e-01
—
1.3e+00
3.2e-01
8.7e-02
cases:20.28%
controls:19.31%
cases:19.35%
controls:16.54%
cases:4.61%
controls:3.69%
—
—
cases:10.60%
controls:3.14%
cases:21.60%
controls:16.61%
cases:39.70%
controls:37.63%
44
419
173
1751
42
359
175
1811
10
80
207
2090
—
23
68
194
2098
46
351
167
1762
79
739
120
1225
MCH [Entitic mass]
28539-5 [3035941]
6.4e-02
1.9e-01
2.3e-01
—
1.3e+00
3.2e-01
8.5e-02
cases:20.28%
controls:19.26%
cases:19.35%
controls:16.50%
cases:4.61%
controls:3.69%
—
—
cases:10.60%
controls:3.14%
cases:21.60%
controls:16.61%
cases:39.70%
controls:37.68%
44
418
173
1752
42
358
175
1812
10
80
207
2090
—
23
68
194
2098
46
351
167
1762
79
740
120
1224
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
6.1e-02
1.9e-01
2.3e-01
—
1.3e+00
3.2e-01
8.5e-02
cases:20.28%
controls:19.31%
cases:19.35%
controls:16.54%
cases:4.61%
controls:3.69%
—
—
cases:10.60%
controls:3.14%
cases:21.60%
controls:16.66%
cases:39.70%
controls:37.68%
44
419
173
1751
42
359
175
1811
10
80
207
2090
—
23
68
194
2098
46
352
167
1761
79
740
120
1224
Leukocytes [#/volume] in Blood
26464-8 [3010813]
5.8e-02
1.9e-01
2.2e-01
—
1.3e+00
3.2e-01
1.0e-01
cases:20.28%
controls:19.35%
cases:19.35%
controls:16.54%
cases:4.61%
controls:3.73%
—
—
cases:10.60%
controls:3.14%
cases:21.60%
controls:16.66%
cases:40.20%
controls:37.73%
44
420
173
1750
42
359
175
1811
10
81
207
2089
—
23
68
194
2098
46
352
167
1761
80
741
119
1223
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
6.1e-02
1.9e-01
2.3e-01
—
1.3e+00
3.2e-01
8.5e-02
cases:20.28%
controls:19.31%
cases:19.35%
controls:16.54%
cases:4.61%
controls:3.69%
—
—
cases:10.60%
controls:3.14%
cases:21.60%
controls:16.66%
cases:39.70%
controls:37.68%
44
419
173
1751
42
359
175
1811
10
80
207
2090
—
23
68
194
2098
46
352
167
1761
79
740
120
1224
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
3.9e-01
—
—
—
—
—
1.3e+00
cases:3.69%
controls:2.53%
—
—
—
—
—
—
—
—
—
—
cases:9.05%
controls:2.70%
8
55
209
2115
—
—
—
—
—
18
53
181
1911
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
4.7e-01
1.2e+00
—
—
—
4.9e-01
5.8e-01
cases:7.83%
controls:5.02%
cases:5.53%
controls:1.66%
—
—
—
—
—
—
cases:2.82%
controls:1.75%
cases:11.06%
controls:6.52%
17
109
200
2061
12
36
205
2134
—
—
—
6
37
207
2076
22
128
177
1836
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
4.7e-01
1.2e+00
—
—
—
4.9e-01
5.8e-01
cases:7.83%
controls:5.02%
cases:5.53%
controls:1.66%
—
—
—
—
—
—
cases:2.82%
controls:1.75%
cases:11.06%
controls:6.52%
17
109
200
2061
12
36
205
2134
—
—
—
6
37
207
2076
22
128
177
1836
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
7.0e-01
9.7e-01
—
—
—
1.2e+00
5.0e-01
cases:6.45%
controls:3.32%
cases:4.61%
controls:1.80%
—
—
—
—
—
—
cases:5.63%
controls:1.70%
cases:11.06%
controls:7.03%
14
72
203
2098
10
39
207
2131
—
—
—
12
36
201
2077
22
138
177
1826
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
—
-1.0e+50
—
—
—
—
1.2e+00
—
—
cases:0.00%
controls:0.78%
—
—
—
—
—
—
—
—
cases:7.54%
controls:2.34%
—
0
17
217
2153
—
—
—
—
15
46
184
1918
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
3.2e-02
3.6e-01
0.0e+00
—
1.2e+00
1.6e-01
3.6e-02
cases:15.67%
controls:15.25%
cases:16.13%
controls:11.80%
cases:2.76%
controls:2.76%
—
—
cases:6.45%
controls:2.08%
cases:14.08%
controls:12.30%
cases:30.65%
controls:29.89%
34
331
183
1839
35
256
182
1914
6
60
211
2110
—
14
45
203
2121
30
260
183
1853
61
587
138
1377
pregabalin; oral
N02BF02 [955152]
7.1e-02
—
-1.0e+50
—
—
1.2e+00
1.1e+00
cases:2.76%
controls:2.58%
—
—
cases:0.00%
controls:0.37%
—
—
—
—
cases:3.29%
controls:1.04%
cases:9.55%
controls:3.41%
6
56
211
2114
—
0
8
217
2162
—
—
7
22
206
2091
19
67
180
1897
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.6e-01
3.5e-01
—
—
1.1e+00
3.7e-01
2.5e-01
cases:12.44%
controls:10.78%
cases:13.36%
controls:9.77%
—
—
—
—
cases:6.45%
controls:2.26%
cases:13.62%
controls:9.84%
cases:28.14%
controls:23.42%
27
234
190
1936
29
212
188
1958
—
—
14
49
203
2117
29
208
184
1905
56
460
143
1504
furosemide; oral, parenteral
C03CA01 [21601518]
3.3e-01
3.4e-01
-1.0e+50
—
-1.0e+50
6.5e-01
9.9e-01
cases:3.23%
controls:2.35%
cases:2.76%
controls:1.98%
cases:0.00%
controls:0.51%
—
—
cases:0.00%
controls:0.74%
cases:3.76%
controls:1.99%
cases:8.04%
controls:3.16%
7
51
210
2119
6
43
211
2127
0
11
217
2159
—
0
16
217
2150
8
42
205
2071
16
62
183
1902
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
3.5e-01
1.8e-01
-1.0e+50
1.0e+50
—
9.5e-01
4.6e-01
cases:7.83%
controls:5.67%
cases:4.15%
controls:3.50%
cases:0.00%
controls:0.51%
cases:2.30%
controls:0.00%
—
—
cases:8.45%
controls:3.45%
cases:15.08%
controls:10.08%
17
123
200
2047
9
76
208
2094
0
11
217
2159
5
0
212
2170
—
18
73
195
2040
30
198
169
1766
Essential (primary) hypertension
I10 [45591453]
1.0e-01
1.1e-01
1.4e+00
—
1.3e+00
9.0e-01
1.6e-01
cases:10.60%
controls:9.68%
cases:5.07%
controls:4.56%
cases:2.76%
controls:0.69%
—
—
cases:3.23%
controls:0.92%
cases:10.80%
controls:4.69%
cases:16.08%
controls:14.00%
23
210
194
1960
11
99
206
2071
6
15
211
2155
—
7
20
210
2146
23
99
190
2014
32
275
167
1689
Upper gastrointestinal surgery
106 [44777669]
5.3e-01
7.1e-01
—
—
—
5.4e-01
7.9e-01
cases:9.68%
controls:5.94%
cases:3.23%
controls:1.61%
—
—
—
—
—
—
cases:2.82%
controls:1.66%
cases:13.07%
controls:6.36%
21
129
196
2041
7
35
210
2135
—
—
—
6
35
207
2078
26
125
173
1839
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6.3e-01
5.2e-01
—
1.0e+50
—
1.7e-01
7.9e-01
cases:5.07%
controls:2.76%
cases:2.30%
controls:1.38%
—
—
cases:3.23%
controls:0.00%
—
—
cases:2.35%
controls:1.99%
cases:12.56%
controls:6.11%
11
60
206
2110
5
30
212
2140
—
7
0
210
2170
—
5
42
208
2071
25
120
174
1844
Internal Medicine
11 [38004456]
8.6e-02
-7.1e-02
—
—
—
4.7e-01
6.0e-01
cases:20.74%
controls:19.35%
cases:8.29%
controls:8.85%
—
—
—
—
—
—
cases:12.68%
controls:8.28%
cases:27.14%
controls:16.90%
45
420
172
1750
18
192
199
1978
—
—
—
27
175
186
1938
54
332
145
1632
Degeneration of macula and posterior pole
H35.39 [2000502319]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
0
7
199
1957
loperamide; oral
A07DA03 [21600646]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
0
9
217
2161
—
—
—
0
7
213
2106
—
Chronic ulcer skin
S97 [2002001061]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
—
Sedation and analgesia
WX002 [2001310758]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
0
7
217
2163
—
—
—
—
—
Acne vulgaris
L70.0 [45581958]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.28%
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
0
6
217
2164
0
5
217
2165
—
—
—
—
0
6
199
1958
cough suppressants and expectorants
R05FB02 [21603442]
3.4e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:2.76%
controls:1.98%
cases:0.00%
controls:0.32%
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
6
43
211
2127
0
7
217
2163
—
—
—
0
6
213
2107
—
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
triamcinolone and antiseptics
D07BB03 [21602150]
-1.0e+50
—
—
—
—
—
5.8e-01
cases:0.00%
controls:1.66%
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:1.43%
0
36
217
2134
—
—
—
—
—
5
28
194
1936
Extensive body CT
JN4BD [2001310899]
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
cases:3.69%
controls:0.00%
—
—
—
—
—
—
—
—
—
8
0
209
2170
—
—
—
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
—
—
—
—
—
—
-1.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:3.41%
—
—
—
—
—
—
6
67
193
1897
Conjunctivitis, unspecified
H10.9 [45591253]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
0
8
199
1956
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:0.61%
—
—
—
—
—
—
5
12
194
1952
Emergency Room and Inpatient Visit
ERIP [262]
9.8e-01
1.0e+00
—
1.0e+50
—
—
7.8e-01
cases:2.76%
controls:1.06%
cases:2.30%
controls:0.83%
—
—
cases:2.76%
controls:0.00%
—
—
—
—
cases:9.05%
controls:4.38%
6
23
211
2147
5
18
212
2152
—
6
0
211
2170
—
—
18
86
181
1878
Monitoring the use of the aid
R5140 [2001310249]
—
—
—
—
—
—
7.8e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:1.17%
—
—
—
—
—
—
5
23
194
1941
Dental X-ray, bite-wing X-ray on one side of the mouth
EB1SA [2001301918]
-2.7e-01
—
-1.0e+50
—
—
—
-8.8e-02
cases:6.45%
controls:8.29%
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
cases:9.55%
controls:10.34%
14
180
203
1990
—
0
5
217
2165
—
—
—
19
203
180
1761
hydrocortisone and antiinfectives
S03CA04 [21605208]
—
-1.0e+50
—
—
—
—
8.4e-01
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
cases:3.02%
controls:1.32%
—
0
8
217
2162
—
—
—
—
6
26
193
1938
Effects of electric current
T75.4 [45585202]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
0
5
199
1959
carbamazepine; oral, rectal
N03AF01 [21604417]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
0
6
213
2107
—
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
1.1e+00
—
—
—
—
1.2e+00
7.1e-01
cases:3.23%
controls:1.11%
—
—
—
—
—
—
—
—
cases:2.35%
controls:0.71%
cases:6.03%
controls:3.05%
7
24
210
2146
—
—
—
—
5
15
208
2098
12
60
187
1904
ciclesonide; nasal
R01AD13 [43534836]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.52%
—
—
—
—
—
—
—
0
11
213
2102
—
Supervision of other normal pregnancy
Z34.8 [45537628]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
217
2160
—
—
—
—
—
—
Cervicalgia
M54.2 [45591867]
—
-1.0e+50
—
—
—
1.0e+50
1.4e+00
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
cases:2.35%
controls:0.00%
cases:2.51%
controls:0.61%
—
0
5
217
2165
—
—
—
5
0
208
2113
5
12
194
1952
clonazepam; oral, parenteral
N03AE01 [21604415]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
0
13
217
2157
—
—
—
0
12
213
2101
—
brinzolamide
S01EC04 [21603696]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
0
6
217
2164
—
—
—
—
0
5
213
2108
—
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
—
empagliflozin; oral
A10BK03 [1123740]
-1.0e+50
—
-1.0e+50
—
—
—
8.8e-01
cases:0.00%
controls:0.60%
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
cases:3.02%
controls:1.27%
0
13
217
2157
—
0
5
217
2165
—
—
—
6
25
193
1939
nimesulide; oral
M01AX17 [21604007]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.92%
—
—
—
—
—
—
0
18
199
1946
chlorhexidine, combinations
D08AC52 [21602208]
-1.0e+50
—
—
—
—
—
5.8e-01
cases:0.00%
controls:1.66%
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:1.43%
0
36
217
2134
—
—
—
—
—
5
28
194
1936
Dental caries
K02 [45552906]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
0
16
217
2154
—
—
—
—
0
5
213
2108
—
General anaesthesia
WX402 [2001310806]
—
—
—
—
—
—
8.0e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.52%
controls:2.09%
—
—
—
—
—
—
9
41
190
1923
CT of urinary organs
KH1AD [2001306328]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
0
6
199
1958
Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
60477-7 [40763531]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
0
6
199
1958
Contact with other sharp object(s)
W26 [45756279]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
0
5
199
1959
Boil/carbuncle
S10 [2002000975]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
0
6
213
2107
—
betaxolol; oral
C07AB05 [21601687]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
0
7
217
2163
—
—
—
—
0
7
213
2106
—
buspirone; oral
N05BE01 [21604601]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
0
7
217
2163
—
—
—
—
—
0
8
199
1956
Primary coxarthrosis, bilateral
M16.0 [45543482]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Balloon angioplasty and drug eluding stent
AN4 [2000200166]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
0
6
199
1958
Diabetes insulin dependent
T89 [2002001130]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
0
9
217
2157
—
—
Intubation
WX704 [2001310820]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:0.51%
—
—
—
—
—
—
5
10
194
1954
Acute appendicitis, unspecified
K35.9 [45557651]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
0
5
213
2108
—
Unspecified dementia
F03 [45566772]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
0
5
199
1959
Helicobacter pylori Ab [Units/volume] in Serum
7900-4 [3017895]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
217
2162
—
—
—
—
—
—
Lyme disease
A69.2 [45595594]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
0
6
199
1958
Swelling
A08 [2002000149]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
0
5
199
1959
Corns and callosities
L84 [45533651]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.51%
0
5
217
2165
—
—
—
—
—
0
10
199
1954
Seborrhoeic keratosis
L82 [45548208]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
Pulmonary Disease
29 [38004472]
1.7e-01
4.3e-01
—
—
1.7e+00
7.2e-01
5.9e-01
cases:7.83%
controls:6.68%
cases:6.45%
controls:4.29%
—
—
—
—
cases:2.76%
controls:0.51%
cases:7.98%
controls:4.07%
cases:14.07%
controls:8.35%
17
145
200
2025
14
93
203
2077
—
—
6
11
211
2155
17
86
196
2027
28
164
171
1800
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Atherosclerotic heart disease
I25.1 [45596196]
8.9e-02
1.0e+00
—
—
—
1.1e+00
3.9e-01
cases:2.76%
controls:2.53%
cases:2.76%
controls:1.01%
—
—
—
—
—
—
cases:3.76%
controls:1.33%
cases:5.53%
controls:3.82%
6
55
211
2115
6
22
211
2148
—
—
—
8
28
205
2085
11
75
188
1889
Blasts/Leukocytes in Blood
26446-5 [3025159]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
1.3e+00
cases:0.00%
controls:0.28%
cases:0.00%
controls:0.28%
—
—
—
—
—
—
cases:0.00%
controls:0.24%
cases:3.52%
controls:1.02%
0
6
217
2164
0
6
217
2164
—
—
—
0
5
213
2108
7
20
192
1944
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
—
—
—
—
—
7.0e-01
-3.3e-03
—
—
—
—
—
—
—
—
—
—
cases:2.35%
controls:1.18%
cases:5.03%
controls:5.04%
—
—
—
—
—
5
25
208
2088
10
99
189
1865
hydrochlorothiazide and potassium-sparing agents
C03EA01 [21601543]
—
9.8e-01
-1.0e+50
—
—
—
—
—
—
cases:2.30%
controls:0.88%
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
5
19
212
2151
0
5
217
2165
—
—
—
—
Chronic kidney disease, unspecified
N18.9 [45553438]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
olmesartan medoxomil; oral
C09CA08 [21601831]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
217
2162
—
—
—
—
—
—
Psychological disorders other
P99 [2002000880]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.32%
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
0
7
217
2163
0
5
217
2165
—
—
—
—
—
Dental examination
Z01.2 [45581002]
6.0e-01
—
—
—
—
—
-2.3e-01
cases:7.37%
controls:4.19%
—
—
—
—
—
—
—
—
—
—
cases:5.53%
controls:6.87%
16
91
201
2079
—
—
—
—
—
11
135
188
1829
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: never
SMOKING-2-3-5 [2002330114]
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.11%
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
0
24
217
2146
0
7
217
2163
—
—
—
—
phenylpropanolamine; oral
R01BA01 [21603209]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
217
2162
—
—
—
—
—
—
clozapine; oral, parenteral
N05AH02 [21604542]
-1.0e+50
-1.0e+50
-1.0e+50
—
—
-1.0e+50
—
cases:0.00%
controls:0.23%
cases:0.00%
controls:0.28%
cases:0.00%
controls:0.28%
—
—
—
—
cases:0.00%
controls:0.28%
—
—
0
5
217
2165
0
6
217
2164
0
6
217
2164
—
—
0
6
213
2107
—
Right side
ZXA00 [2001311346]
-6.6e-02
-1.0e+50
—
—
—
1.3e+00
8.2e-01
cases:2.76%
controls:2.95%
cases:0.00%
controls:0.41%
—
—
—
—
—
—
cases:2.35%
controls:0.66%
cases:6.03%
controls:2.75%
6
64
211
2106
0
9
217
2161
—
—
—
5
14
208
2099
12
54
187
1910
Fat metabolism disorder associated with chronic coronary artery disease
213 [2001600209]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
217
2163
—
—
—
—
—
—
triamcinolone; nasal
R01AD11 [21605052]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.65%
cases:0.00%
controls:0.23%
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
0
14
217
2156
0
5
217
2165
—
—
—
0
7
213
2106
—
Fracture of lateral malleolus
S82.6 [45569819]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
217
2161
—
—
—
—
—
—
Maternal and Fetal Medicine
OMOP4821963 [45756780]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
49891-5 [3029511]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
—
ipratropium bromide; nasal
R01AX03 [21603199]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
0
10
217
2160
—
—
—
—
—
0
6
199
1958
Carpal tunnel syndrome
G56.0 [45566891]
—
—
—
—
—
—
6.5e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:1.32%
—
—
—
—
—
—
5
26
194
1938
General and Unspecified, Result test/procedure
A60 [2002000194]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
217
2163
—
—
—
—
—
—
Clinical photography of mouth and teeth
SBB00 [2001310298]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
217
2163
—
—
—
—
—
—
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
—
—
—
—
—
-1.0e+50
4.6e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
cases:3.52%
controls:2.24%
—
—
—
—
—
0
14
213
2099
7
44
192
1920
almotriptan; oral
N02CC05 [21604380]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.36%
0
7
217
2163
—
—
—
—
—
0
7
199
1957
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:0.56%
—
—
—
—
—
—
5
11
194
1953
intermediate-acting sulfonamides - combinations
J01EC20 [21602948]
3.4e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:2.76%
controls:1.98%
cases:0.00%
controls:0.32%
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
6
43
211
2127
0
7
217
2163
—
—
—
0
6
213
2107
—
trimethoprim; oral, parenteral
J01EA01 [21602931]
1.5e-01
—
—
—
—
—
7.5e-01
cases:2.30%
controls:1.98%
—
—
—
—
—
—
—
—
—
—
cases:4.52%
controls:2.19%
5
43
212
2127
—
—
—
—
—
9
43
190
1921
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
4.3e-01
5.5e-01
—
—
—
—
6.2e-01
cases:5.07%
controls:3.36%
cases:2.76%
controls:1.61%
—
—
—
—
—
—
—
—
cases:8.04%
controls:4.48%
11
73
206
2097
6
35
211
2135
—
—
—
—
16
88
183
1876
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2500B [2000402295]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
217
2162
—
—
—
—
—
—
Other senile cataract
H25.8 [45605644]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
0
5
213
2108
—
PEF monitoring instruction
SPAT1058 [2001700159]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
0
5
213
2108
—
formoterol, glycopyrronium bromide and beclometasone
R03AL09 [1502099]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
0
5
199
1959
azithromycin; oral, parenteral
J01FA10 [21602978]
-3.1e-02
2.3e-01
—
—
—
—
2.4e-01
cases:7.83%
controls:8.06%
cases:2.76%
controls:2.21%
—
—
—
—
—
—
—
—
cases:8.54%
controls:6.82%
17
175
200
1995
6
48
211
2122
—
—
—
—
17
134
182
1830
Dysuria
R30.0 [45592416]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.51%
—
—
—
—
—
—
0
10
199
1954
Acute tonsillitis
J03 [45552876]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
—
Chest pain NOS
A11 [2002000152]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
217
2161
—
—
—
—
—
—
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: occasional
SMOKING-1-1-2 [2002330117]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
217
2163
—
—
—
—
—
—
Cathetrisation of vein
TPH04 [2001309597]
8.5e-01
—
—
—
—
—
1.1e+00
cases:2.76%
controls:1.20%
—
—
—
—
—
—
—
—
—
—
cases:5.53%
controls:1.93%
6
26
211
2144
—
—
—
—
—
11
38
188
1926
Short MRI examination of brain with median intensity magnet
AA1AG [2001300107]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Acute appendicitis, Without mention of peritonitis
5409X [2000404342]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
loperamide oxide; oral
A07DA05 [21600648]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
0
9
217
2161
—
—
—
0
7
213
2106
—
macrogol; oral
A06AD15 [21600575]
—
-1.0e+50
—
—
—
-1.0e+50
1.5e+00
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
cases:0.00%
controls:0.28%
cases:3.02%
controls:0.66%
—
0
5
217
2165
—
—
—
0
6
213
2107
6
13
193
1951
Impacted cerumen
H61.2 [45562307]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
217
2159
—
—
—
—
—
—
Endovascular dilatation of coronary arteries (PTCA)
FN1AT [2001303062]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
0
10
217
2160
—
—
—
—
—
0
5
199
1959
pivmecillinam; oral
J01CA08 [21602827]
1.8e-01
—
—
—
—
—
4.8e-01
cases:3.69%
controls:3.09%
—
—
—
—
—
—
—
—
—
—
cases:4.52%
controls:2.85%
8
67
209
2103
—
—
—
—
—
9
56
190
1908
Acromioplastia, arthroscopic
NBG15 [2001307302]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
0
9
199
1955
cloxacillin; oral, parenteral
J01CF02 [21602854]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
217
2161
—
—
—
—
—
—
Dorsalgia, unspecified
M54.9 [45538791]
1.3e+00
—
—
—
—
—
—
cases:2.76%
controls:0.74%
—
—
—
—
—
—
—
—
—
—
—
—
6
16
211
2154
—
—
—
—
—
—
Follow-up examination after treatment of fracture
Z09.4 [45561611]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
—
Extended examination of mouth
SAA03 [2001310276]
-1.4e-01
—
-1.0e+50
—
—
—
-1.9e-01
cases:4.15%
controls:4.75%
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
cases:5.03%
controls:6.01%
9
103
208
2067
—
0
6
217
2164
—
—
—
10
118
189
1846
Contusion of lower back and pelvis
S30.0 [45549279]
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
cases:2.30%
controls:0.00%
—
—
—
—
—
—
—
—
—
5
0
212
2170
—
—
—
desonide
D07AB08 [21602112]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.38%
—
—
—
—
—
—
—
0
8
213
2105
—
CPAP therapy
WX723 [2001310826]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
G55.1*M51.1 [2000502168]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
0
5
199
1959
Diabetic maculopathy and Type 2 diabetes mellitus, with ophthalmic complications
H36.01*E11.3 [2000503956]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
0
6
199
1958
Visit based on need for special support
SPAT1389 [2001700489]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
0
7
217
2163
—
—
—
—
—
0
5
199
1959
Other specified prophylactic measures
Z29.8 [45537623]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
0
5
199
1959
Periodontal treatment, brief
SDA02 [2001310327]
—
—
—
—
—
—
3.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.54%
controls:5.35%
—
—
—
—
—
—
15
105
184
1859
Problems related to unwanted pregnancy
Z64.0 [45581053]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Anaemia, unspecified
D64.9 [45600610]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
scopolamine
A04AD01 [21600499]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
0
5
217
2165
—
—
—
0
5
213
2108
—
amitriptyline; oral, parenteral
N06AA09 [21604696]
6.6e-01
—
—
—
—
8.2e-01
9.4e-01
cases:3.69%
controls:1.94%
—
—
—
—
—
—
—
—
cases:3.29%
controls:1.47%
cases:5.53%
controls:2.24%
8
42
209
2128
—
—
—
—
7
31
206
2082
11
44
188
1920
Elevated blood-pressure reading, without diagnosis of hypertension
R03.0 [45553712]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
—
Insertion of (intrauterine) contraceptive device
Z30.1 [45537626]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
217
2161
—
—
—
—
—
—
Surveillance of (intrauterine) contraceptive device
Z30.5 [45547300]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
0
5
217
2165
—
—
—
—
—
0
6
199
1958
Abdominal CT examination
JN3AD [2001305554]
2.1e+00
—
—
—
—
—
1.3e+00
cases:2.30%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:3.52%
controls:0.97%
5
6
212
2164
—
—
—
—
—
7
19
192
1945
General and Unspecified, Clarification/discussion RFE/demand
A48 [2002000182]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
0
8
199
1956
Disorders of lipoprotein metabolism and other lipidaemias
E78 [45557140]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
ambroxol; oral
R05CB06 [21603385]
—
—
—
—
—
—
5.5e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.52%
controls:2.65%
—
—
—
—
—
—
9
52
190
1912
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
217
2163
—
—
—
—
—
—
Transurethral resection of prostate
KED22 [2001306138]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
0
7
199
1957
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
0
8
199
1956
Vaccination
SPAT1325 [2001700426]
-1.1e-01
—
—
—
—
—
—
cases:3.23%
controls:3.59%
—
—
—
—
—
—
—
—
—
—
—
—
7
78
210
2092
—
—
—
—
—
—
mesalazine; oral, rectal
A07EC02 [21600664]
1.6e+00
1.6e+00
—
—
—
1.5e+00
1.0e+00
cases:3.23%
controls:0.65%
cases:2.76%
controls:0.60%
—
—
—
—
—
—
cases:2.82%
controls:0.66%
cases:3.02%
controls:1.12%
7
14
210
2156
6
13
211
2157
—
—
—
6
14
207
2099
6
22
193
1942
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
XFP96 [2001303143]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
—
Vitreous haemorrhage
H43.1 [45543053]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Base excess in Arterial blood by calculation
1925-7 [3003396]
-1.0e+50
—
—
—
—
-1.0e+50
9.6e-01
cases:0.00%
controls:0.65%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
cases:3.02%
controls:1.17%
0
14
217
2156
—
—
—
—
0
5
213
2108
6
23
193
1941
Emergency visit or other similar visit involving procedures
WYA05 [2001310871]
2.4e-01
2.8e-01
—
—
-1.0e+50
-8.7e-02
2.0e-02
cases:8.76%
controls:7.05%
cases:3.69%
controls:2.81%
—
—
—
—
cases:0.00%
controls:0.37%
cases:2.35%
controls:2.56%
cases:8.04%
controls:7.89%
19
153
198
2017
8
61
209
2109
—
—
0
8
217
2158
5
54
208
2059
16
155
183
1809
Lipid disorder
T93 [2002001134]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
0
7
217
2163
—
—
—
—
—
0
8
199
1956
Diffuse brain injury
S06.2 [45592516]
—
—
—
1.0e+50
—
1.0e+50
—
—
—
—
—
—
—
cases:2.76%
controls:0.00%
—
—
cases:3.29%
controls:0.00%
—
—
—
—
—
6
0
211
2170
—
7
0
206
2113
—
Asthma, unspecified
J45.9 [45562456]
4.9e-01
—
-1.0e+50
—
-1.0e+50
—
2.4e-01
cases:2.30%
controls:1.43%
—
—
cases:0.00%
controls:0.28%
—
—
cases:0.00%
controls:0.23%
—
—
cases:3.02%
controls:2.39%
5
31
212
2139
—
0
6
217
2164
—
0
5
217
2161
—
6
47
193
1917
Diabetes mellitus screening
171183004 [4064918]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
0
5
217
2165
—
—
—
—
—
0
9
199
1955
orphenadrine, combinations
M03BC51 [21604113]
3.9e-01
1.2e+00
—
—
—
—
9.8e-01
cases:3.69%
controls:2.53%
cases:2.76%
controls:0.83%
—
—
—
—
—
—
—
—
cases:6.53%
controls:2.55%
8
55
209
2115
6
18
211
2152
—
—
—
—
13
50
186
1914
Deposits [accretions] on teeth betel
K03.65 [2000502690]
6.8e-01
—
—
—
—
—
-1.4e-02
cases:3.23%
controls:1.66%
—
—
—
—
—
—
—
—
—
—
cases:3.52%
controls:3.56%
7
36
210
2134
—
—
—
—
—
7
70
192
1894
Nutrition survey
SPAT1139 [2001700240]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
0
5
199
1959
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.76%
—
—
—
—
—
—
6
15
193
1949
salmeterol; inhalant
R03AC12 [21603266]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.28%
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
0
5
217
2165
—
—
—
—
—
Limited function/disability (L)
L28 [2002000647]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.88%
—
—
—
—
—
—
—
—
—
—
—
—
0
19
217
2151
—
—
—
—
—
—
lercanidipine; oral
C08CA13 [21601759]
-1.0e+50
—
-1.0e+50
—
-1.0e+50
—
-1.3e-02
cases:0.00%
controls:1.84%
—
—
cases:0.00%
controls:0.60%
—
—
cases:0.00%
controls:0.46%
—
—
cases:2.51%
controls:2.55%
0
40
217
2130
—
0
13
217
2157
—
0
10
217
2156
—
5
50
194
1914
General medical examination
Z00.0 [45585791]
8.5e-01
—
—
—
—
—
—
cases:4.61%
controls:2.03%
—
—
—
—
—
—
—
—
—
—
—
—
10
44
207
2126
—
—
—
—
—
—
Diabetes mellitus arising in pregnancy
O24.4 [45543922]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
217
2159
—
—
—
—
—
—
Bacteria identified in Blood by Culture
600-7 [3023368]
8.8e-01
—
—
—
—
9.2e-01
9.1e-01
cases:3.69%
controls:1.57%
—
—
—
—
—
—
—
—
cases:2.35%
controls:0.95%
cases:8.04%
controls:3.41%
8
34
209
2136
—
—
—
—
5
20
208
2093
16
67
183
1897
Dyspnoea
R06.0 [45558449]
—
-1.0e+50
—
—
—
-1.0e+50
7.3e-01
—
—
cases:0.00%
controls:0.88%
—
—
—
—
—
—
cases:0.00%
controls:0.66%
cases:4.52%
controls:2.24%
—
0
19
217
2151
—
—
—
0
14
213
2099
9
44
190
1920
Hand and fingers X-ray examination
ND2AA [2001307607]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
0
5
213
2108
—
Removal of sutures
SPAT1153 [2001700254]
2.5e-01
—
—
—
—
—
9.5e-01
cases:3.23%
controls:2.53%
—
—
—
—
—
—
—
—
—
—
cases:7.04%
controls:2.85%
7
55
210
2115
—
—
—
—
—
14
56
185
1908
Gastro-oesophageal reflux disease
K21 [45586708]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Triglyceride [Moles/volume] in Serum or Plasma
14927-8 [3025839]
1.2e+00
—
—
—
-1.0e+50
-1.0e+50
2.3e-01
cases:4.15%
controls:1.29%
—
—
—
—
—
—
cases:0.00%
controls:0.28%
cases:0.00%
controls:1.14%
cases:6.53%
controls:5.24%
9
28
208
2142
—
—
—
0
6
217
2160
0
24
213
2089
13
103
186
1861
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
INR in Blood by Coagulation assay
34714-6 [3032080]
4.9e-01
4.0e-01
—
1.0e+50
—
8.7e-01
6.5e-01
cases:5.53%
controls:3.46%
cases:4.15%
controls:2.81%
—
—
cases:5.53%
controls:0.00%
—
—
cases:6.10%
controls:2.65%
cases:12.56%
controls:6.98%
12
75
205
2095
9
61
208
2109
—
12
0
205
2170
—
13
56
200
2057
25
137
174
1827
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
217
2161
—
—
—
—
—
—
amiodarone; oral, parenteral
C01BD01 [21600270]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
0
9
199
1955
insulin aspart; parenteral
A10AB05 [21600719]
-5.5e-01
-5.5e-01
—
—
—
-3.8e-01
-5.2e-01
cases:2.30%
controls:3.92%
cases:2.30%
controls:3.92%
—
—
—
—
—
—
cases:2.82%
controls:4.07%
cases:3.52%
controls:5.80%
5
85
212
2085
5
85
212
2085
—
—
—
6
86
207
2027
7
114
192
1850
Physiotherapy
R4110 [2001310233]
6.2e-01
—
—
1.0e+50
—
1.6e+00
1.0e+00
cases:4.61%
controls:2.53%
—
—
—
—
cases:2.76%
controls:0.00%
—
—
cases:3.76%
controls:0.80%
cases:7.04%
controls:2.70%
10
55
207
2115
—
—
6
0
211
2170
—
8
17
205
2096
14
53
185
1911
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
-1.0e+50
—
—
—
—
—
9.2e-01
cases:0.00%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:1.02%
0
11
217
2159
—
—
—
—
—
5
20
194
1944
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
4.1e-01
—
-1.0e+50
—
—
—
1.5e-01
cases:3.23%
controls:2.17%
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
cases:5.53%
controls:4.79%
7
47
210
2123
—
0
5
217
2165
—
—
—
11
94
188
1870
Umbilical hernia without obstruction or gangrene
K42.9 [45591589]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:0.46%
—
—
—
—
—
—
5
9
194
1955
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:1.02%
—
—
—
—
—
—
6
20
193
1944
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
217
2161
—
—
—
—
—
—
timolol, combinations
S01ED51 [21603705]
-1.0e+50
-1.0e+50
—
—
-1.0e+50
-1.0e+50
—
cases:0.00%
controls:0.97%
cases:0.00%
controls:1.01%
—
—
—
—
cases:0.00%
controls:0.37%
cases:0.00%
controls:0.95%
—
—
0
21
217
2149
0
22
217
2148
—
—
0
8
217
2158
0
20
213
2093
—
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
0
7
217
2163
—
—
—
—
—
Restoration involving the entire crown of the tooth
SFA40 [2001310361]
3.6e-01
—
—
—
—
—
1.3e-01
cases:2.76%
controls:1.94%
—
—
—
—
—
—
—
—
—
—
cases:3.52%
controls:3.11%
6
42
211
2128
—
—
—
—
—
7
61
192
1903
combinations of corticosteroids
D07AB30 [21602118]
-1.7e-01
2.6e-01
—
—
—
2.7e-01
5.3e-01
cases:7.37%
controls:8.62%
cases:4.15%
controls:3.23%
—
—
—
—
—
—
cases:5.16%
controls:3.98%
cases:14.57%
controls:9.16%
16
187
201
1983
9
70
208
2100
—
—
—
11
84
202
2029
29
180
170
1784
Coronary flow reserve measurement with pressure wire
FN1CB [2001303007]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
0
7
199
1957
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
—
-1.0e+50
—
—
-1.0e+50
-1.0e+50
9.6e-01
—
—
cases:0.00%
controls:0.37%
—
—
—
—
cases:0.00%
controls:0.23%
cases:0.00%
controls:0.38%
cases:3.52%
controls:1.37%
—
0
8
217
2162
—
—
0
5
217
2161
0
8
213
2105
7
27
192
1937
Hemoglobin.gastrointestinal [Presence] in Stool
2335-8 [3016251]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
Synovitis and tenosynovitis, unspecified
M65.9 [45567618]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
0
5
217
2165
—
—
—
—
—
0
5
199
1959
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
1.1e+00
cases:0.00%
controls:0.32%
cases:0.00%
controls:0.28%
—
—
—
—
—
—
cases:0.00%
controls:0.24%
cases:3.52%
controls:1.17%
0
7
217
2163
0
6
217
2164
—
—
—
0
5
213
2108
7
23
192
1941
Psychological sympt/compl other
P29 [2002000823]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.07%
—
—
—
—
—
—
0
21
199
1943
Headache
N01 [2002000720]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
cases:0.00%
controls:0.28%
cases:0.00%
controls:0.41%
—
0
8
217
2162
—
—
—
0
6
213
2107
0
8
199
1956
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10886-0 [3005013]
—
—
—
—
—
1.0e+00
-3.1e-01
—
—
—
—
—
—
—
—
—
—
cases:3.76%
controls:1.42%
cases:4.52%
controls:6.06%
—
—
—
—
—
8
30
205
2083
9
119
190
1845
Headache
R51.80 [2000503603]
—
—
—
—
—
—
4.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.51%
controls:1.58%
—
—
—
—
—
—
5
31
194
1933
Irrigation or wax removal of outer auditory canal
SPAT1033 [2001700134]
7.0e-01
—
—
—
—
—
2.8e-01
cases:2.30%
controls:1.15%
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:2.29%
5
25
212
2145
—
—
—
—
—
6
45
193
1919
Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]
5.6e-01
1.5e-01
—
—
-1.0e+50
2.2e-02
1.1e-01
cases:5.53%
controls:3.23%
cases:3.69%
controls:3.18%
—
—
—
—
cases:0.00%
controls:0.37%
cases:3.29%
controls:3.22%
cases:10.05%
controls:9.06%
12
70
205
2100
8
69
209
2101
—
—
0
8
217
2158
7
68
206
2045
20
178
179
1786
Free T4 and TSH panel - Serum or Plasma
24348-5 [3001019]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
Basal cell carcinoma, NOS, of skin, NOS
8090/3-C44.9 [44505057]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Gastroenterology
10 [38004455]
6.5e-01
7.0e-01
—
—
—
8.7e-01
5.1e-01
cases:5.07%
controls:2.72%
cases:2.30%
controls:1.15%
—
—
—
—
—
—
cases:2.35%
controls:0.99%
cases:7.04%
controls:4.33%
11
59
206
2111
5
25
212
2145
—
—
—
5
21
208
2092
14
85
185
1879
HLA-B27 [Presence]
4821-5 [3008898]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
217
2162
—
—
—
—
—
—
Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
0
7
199
1957
dextromethorphan, combinations; oral
N07XX59 [43534835]
3.4e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:2.76%
controls:1.98%
cases:0.00%
controls:0.32%
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
6
43
211
2127
0
7
217
2163
—
—
—
0
6
213
2107
—
Guidance related to psychoactive substances / risk behaviour
SPAT1309 [2001700410]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.36%
0
5
217
2165
—
—
—
—
—
0
7
199
1957
short-acting sulfonamides - combinations
J01EB20 [21602943]
3.4e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:2.76%
controls:1.98%
cases:0.00%
controls:0.32%
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
6
43
211
2127
0
7
217
2163
—
—
—
0
6
213
2107
—
Amphetamines [Presence] in Urine
3349-8 [3027944]
—
—
—
—
—
-1.0e+50
6.7e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
cases:3.52%
controls:1.83%
—
—
—
—
—
0
5
213
2108
7
36
192
1928
Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
63453-5 [40766183]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
0
5
199
1959
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.51%
—
—
—
—
—
—
0
10
199
1954
Hematology
82 [38004501]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.55%
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
0
12
217
2158
0
8
217
2162
—
—
—
—
—
FEV1/FVC --post bronchodilation
69970-2 [42868459]
—
—
—
—
—
-1.0e+50
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
cases:2.51%
controls:0.46%
—
—
—
—
—
0
6
213
2107
5
9
194
1955
Tooth plaque
K03.66 [2000502691]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
0
6
213
2107
—
Opiates [Presence] in Urine
3879-4 [3027008]
—
—
—
—
—
-1.0e+50
7.0e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
cases:3.52%
controls:1.78%
—
—
—
—
—
0
6
213
2107
7
35
192
1929
Sentinel node biopsy
PJA12 [2001309627]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Excision of other lesion extending through all layers of skin in upper limb
QCE10 [2001309914]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Psychiatric treatment plan, standard
ICB01 [2001304098]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
0
8
199
1956
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.52%
controls:0.66%
—
—
—
—
—
—
7
13
192
1951
Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21613-5 [3006093]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.69%
—
—
—
—
—
—
—
—
—
—
—
—
0
15
217
2155
—
—
—
—
—
—
Hand Surgery
40 [38004480]
2.9e-01
—
-1.0e+50
—
—
1.3e+00
9.3e-01
cases:2.76%
controls:2.07%
—
—
cases:0.00%
controls:0.32%
—
—
—
—
cases:3.76%
controls:1.04%
cases:7.54%
controls:3.11%
6
45
211
2125
—
0
7
217
2163
—
—
8
22
205
2091
15
61
184
1903
Shoulder X-ray examination without contrast
NB1AA [2001307225]
—
—
—
1.0e+50
—
—
1.8e+00
—
—
—
—
—
—
cases:2.30%
controls:0.00%
—
—
—
—
cases:2.51%
controls:0.41%
—
—
—
5
0
212
2170
—
—
5
8
194
1956
cough suppressants and mucolytics
R05FB01 [21603441]
3.4e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:2.76%
controls:1.98%
cases:0.00%
controls:0.32%
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
6
43
211
2127
0
7
217
2163
—
—
—
0
6
213
2107
—
Chronic prostatitis
N41.1 [45539048]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
Other specified urinary incontinence
N39.4 [45577525]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
0
7
199
1957
Retained molar with obstruction in the lower jaw
K01.17 [2000502662]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.46%
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
0
10
217
2160
0
8
217
2162
—
—
—
—
—
Unspecified acute lower respiratory infection
J22 [45586665]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Cell count panel - Pleural fluid
34561-1 [3045788]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
0
5
199
1959
tolterodine; oral
G04BD07 [21602640]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
217
2163
—
—
—
—
—
—
propranolol; oral, parenteral
C07AA05 [21601670]
-1.9e-01
—
—
—
—
—
2.0e-01
cases:2.30%
controls:2.76%
—
—
—
—
—
—
—
—
—
—
cases:3.52%
controls:2.90%
5
60
212
2110
—
—
—
—
—
7
57
192
1907
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
0
8
199
1956
glyceryl trinitrate; local oral, oral, sublingual, transdermal
C01DA02 [21600317]
-2.4e-01
—
—
—
—
—
2.0e-01
cases:2.76%
controls:3.50%
—
—
—
—
—
—
—
—
—
—
cases:3.52%
controls:2.90%
6
76
211
2094
—
—
—
—
—
7
57
192
1907
Tobacco use
Z72.0 [45581063]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
217
2165
—
—
—
—
—
—
Fracture of rib
S22.3 [45573285]
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
cases:4.15%
controls:0.00%
—
—
—
—
—
—
—
—
—
9
0
208
2170
—
—
—
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
217
2159
—
—
—
—
—
—
oxazepam; oral
N05BA04 [21604569]
4.7e-01
6.8e-01
—
—
—
7.0e-01
3.4e-01
cases:5.07%
controls:3.23%
cases:3.23%
controls:1.66%
—
—
—
—
—
—
cases:3.29%
controls:1.66%
cases:5.03%
controls:3.62%
11
70
206
2100
7
36
210
2134
—
—
—
7
35
206
2078
10
71
189
1893
Hyperplasia of prostate
N40 [45563015]
6.0e-01
—
-1.0e+50
—
—
—
4.8e-01
cases:3.23%
controls:1.80%
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
cases:5.03%
controls:3.16%
7
39
210
2131
—
0
5
217
2165
—
—
—
10
62
189
1902
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
0
6
217
2164
—
—
—
0
5
213
2108
—
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
O24.0 [45558213]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
0
9
199
1955
Standard cardiac ultrasound examination
FM1AE [2001303278]
—
-1.0e+50
—
—
—
—
6.0e-01
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
—
—
cases:3.02%
controls:1.68%
—
0
9
217
2161
—
—
—
—
6
33
193
1931
oxcarbazepine; oral
N03AF02 [21604418]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
217
2161
—
—
—
—
—
—
Epistaxis
R04.0 [45606791]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
0
9
199
1955
Endovenous obliteration of v.saphena magna
PHM76 [2001309538]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
0
6
199
1958
Benign neoplasm: Rectum
D12.8 [45595734]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
217
2164
—
—
—
—
—
—
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
4.3e-01
—
—
—
—
—
—
cases:3.23%
controls:2.12%
—
—
—
—
—
—
—
—
—
—
—
—
7
46
210
2124
—
—
—
—
—
—
Neutrophils [#/volume] in Blood
26499-4 [3017732]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.02%
—
—
—
—
—
—
0
20
199
1944
Cardiodefibrillation
TFP20 [2001303224]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
217
2160
—
—
—
—
—
—

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
121
797
2.17
7.23
13.5
12.2
1.19
1.20
inr
0.10
106
663
105
701
1.96
5.59
3.8
3.4
20.49
39.28
ng/l
2.03
70
462
143
1070
1.99
5.35
6.5
6.1
6.94
6.75
mmol/l
0.41
136
1015
44
234
2.10
4.28
1.7
1.7
—
—
—
0
0
56
332
1.93
4.02
2.9
3.1
—
—
—
0
0
63
402
1.80
3.56
1.6
1.8
0.87
1.42
mg/l
1.56
44
310
44
253
1.93
3.43
3.5
2.6
27.15
24.68
%
0.33
38
245
27
131
2.21
3.29
4.5
2.8
7.42
7.42
ph
0.04
27
110
62
406
1.74
3.17
3.9
3.4
1.02
1.02
kg/l
0.51
49
270
105
792
1.63
3.13
3.1
2.8
—
—
estimate
—
0
0
78
546
1.67
3.12
2.8
2.5
—
—
—
0
0
70
484
1.66
2.90
4.5
3.3
0.00
0.01
estimate
0.50
22
163
45
275
1.80
2.89
3.6
2.6
2.29
2.31
g/l
0.05
40
259
47
293
1.77
2.83
3.7
2.6
14.97
14.37
umol/l
0.12
42
275
10
28
3.69
2.82
1.1
2.8
—
—
—
0
0
26
133
2.08
2.79
2.7
2.0
0.00
0.00
estimate
—
6
34
44
274
1.76
2.65
2.4
2.4
—
—
—
0
0
116
923
1.55
2.60
3.9
3.4
0.00
0.00
estimate
-0.00
24
172
8
20
4.11
2.59
1.0
1.8
—
—
—
0
0
94
717
1.55
2.53
3.9
3.2
0.00
0.00
estimate
-0.00
22
152
116
935
1.52
2.38
4.0
3.4
0.00
0.00
estimate
-0.00
22
158
23
121
2.01
2.31
2.6
1.7
6.00
6.14
ph
0.23
14
69
113
915
1.49
2.21
4.0
3.4
0.00
0.00
estimate
-0.00
25
171
9
30
3.08
2.17
5.3
3.1
40.78
24.26
mg/l
—
9
21
69
507
1.53
2.14
4.3
4.7
—
—
—
0
0
101
811
1.46
2.00
10.6
9.1
1.20
1.20
mmol/l
0.46
91
725
22
124
1.86
1.84
3.1
3.8
—
—
—
0
0
8
29
2.82
1.81
1.0
1.3
—
—
—
0
0
11
47
2.41
1.81
1.3
2.0
1.58
1.39
ratio
—
6
23
75
579
1.45
1.79
6.6
4.5
13.70
11.64
mg/mmol
0.12
53
392
18
96
1.95
1.76
5.7
2.7
—
—
—
0
0
7
24
2.98
1.73
1.1
1.0
—
—
—
0
0
197
1836
1.79
1.72
19.4
14.5
25.16
24.66
mg/l
0.06
175
1495
21
120
1.83
1.69
9.3
10.8
24.91
24.32
mmol/l
0.44
21
114
20
113
1.85
1.67
6.1
8.6
—
—
—
0
0
72
558
1.43
1.67
4.1
3.1
24.00
171.53
e6/l
0.66
61
418
11
49
2.31
1.66
2.7
2.1
25.17
93.25
ug/min
—
6
26
80
633
1.42
1.65
4.2
3.7
19.36
100.97
e6/l
0.99
64
443
37
251
1.57
1.62
9.2
7.3
1.04
1.00
mmol/l
0.38
37
242
6
141
0.41
1.59
1.5
2.0
207.83
232.69
pmol/l
—
6
132
15
78
1.99
1.58
3.5
2.1
0.00
0.00
estimate
—
5
26
72
563
1.42
1.58
5.7
3.8
67.45
74.38
mg/l
0.10
56
393
64
492
1.43
1.54
2.6
2.7
380.65
368.19
umol/l
0.41
54
438
13
65
2.06
1.52
4.2
4.2
467.50
476.94
mg/l
—
8
34
19
110
1.80
1.48
2.8
3.9
1.22
1.22
mmol/l
0.02
19
100
6
23
2.65
1.37
1.0
1.6
1.63
1.53
mmol/l
—
6
23
15
83
1.87
1.35
6.7
10.9
1.90
1.61
%
0.39
15
76
72
875
0.73
1.32
2.8
2.9
—
—
—
0
0
31
213
1.53
1.30
1.3
1.3
—
—
—
0
0
24
155
1.62
1.29
3.5
3.1
5.25
4.85
kpa
0.32
24
150
20
123
1.69
1.29
2.4
2.3
—
—
—
0
0
78
637
1.35
1.28
5.7
3.7
9.32
9.19
mmol/l
0.08
67
553
41
303
1.44
1.21
1.8
1.8
418.94
43657145.06
pmol/l
0.50
35
268
95
806
1.32
1.19
10.7
11.1
0.00
0.00
e9/l
0.54
80
649
90
758
1.32
1.19
3.8
3.2
6.12
6.12
ph
0.01
59
455
8
39
2.09
1.16
1.3
2.6
—
—
—
0
0
11
58
1.94
1.14
1.5
1.9
—
—
—
0
0
13
73
1.83
1.13
7.5
12.1
0.67
0.92
%
2.14
13
66
65
527
1.33
1.11
1.4
1.3
—
—
—
0
0
18
113
1.65
1.09
5.6
3.4
—
—
—
0
0
10
176
0.55
1.05
11.0
12.7
—
—
—
0
0
0
29
0.00
0.98
0.0
1.4
—
1.40
—
0
19
0
30
0.00
0.98
0.0
1.4
—
—
—
0
0
0
31
0.00
0.97
0.0
1.6
—
—
—
0
0
0
32
0.00
0.96
0.0
1.1
—
—
—
0
0
6
27
2.26
0.94
1.2
1.1
—
—
—
0
0
17
110
1.59
0.94
2.5
2.6
0.69
0.63
%
0.37
17
110
20
136
1.52
0.90
2.4
2.2
—
—
—
0
0
58
477
1.29
0.89
3.3
3.0
0.53
0.37
e6/l
0.20
45
339
20
137
1.51
0.88
2.4
2.2
—
—
—
0
0
149
1374
1.27
0.86
9.8
8.5
78.63
76.47
u/l
0.40
143
1319
35
268
1.36
0.86
5.4
9.9
104.60
104.30
mmol/l
0.20
35
268
12
189
0.61
0.86
1.0
1.7
—
—
—
0
0
11
177
0.60
0.86
1.4
2.0
35.82
38.36
nmol/l
0.20
11
171
20
138
1.49
0.85
2.4
2.0
—
—
—
0
0
15
97
1.59
0.84
1.5
2.1
—
—
—
0
0
58
481
1.28
0.83
4.1
4.1
7.40
7.40
ph
0.51
45
353
6
33
1.84
0.79
1.3
1.4
—
—
—
0
0
25
184
1.41
0.78
5.8
4.0
7.37
7.39
ph
0.83
16
107
116
1049
1.23
0.76
8.6
10.1
4.73
4.13
e9/l
1.83
102
920
53
440
1.27
0.75
1.3
1.3
0.76
1.15
u/ml
1.21
18
122
44
357
1.29
0.75
4.3
3.6
137.29
829.82
ng/l
1.56
34
268
52
618
0.79
0.74
2.2
2.8
0.56
0.68
ug/l
1.00
31
340
7
39
1.82
0.73
9.3
18.4
9.43
11.82
mmol/l
—
7
34
7
39
1.82
0.73
9.3
18.4
105.00
104.65
mmol/l
—
7
34
5
25
2.02
0.73
2.0
1.7
12.92
11.70
%
—
5
25
5
25
2.02
0.73
1.4
2.8
1.21
1.18
mmol/l
—
5
25
5
25
2.02
0.73
1.4
2.8
103.80
105.80
mmol/l
—
5
25
5
25
2.02
0.73
1.4
2.8
4.22
4.10
mmol/l
—
5
25
31
240
1.34
0.73
2.0
3.1
8.43
7.41
e9/l
0.09
26
215
24
178
1.39
0.72
5.3
3.9
1.67
1.87
mmol/l
0.13
24
152
5
26
1.94
0.71
2.6
1.7
23.00
20.18
u/ml
—
5
26
62
529
1.24
0.70
4.7
6.0
—
—
—
0
0
19
136
1.44
0.69
2.5
2.3
—
—
—
0
0
63
540
1.23
0.68
3.2
2.8
0.00
0.01
estimate
0.50
20
145
81
716
1.21
0.65
2.0
1.9
91.49
96.10
pmol/l
0.46
54
393
48
402
1.25
0.64
1.5
1.4
2.33
2.58
g/l
0.88
37
265
6
105
0.56
0.63
3.7
3.9
4.62
4.52
pmol/l
—
6
93
10
151
0.65
0.62
1.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
2.0
—
35.93
—
0
21
34
276
1.27
0.59
2.6
2.8
1.54
0.92
e6/l
0.34
16
131
8
54
1.50
0.58
1.7
2.9
7.42
7.41
ph
—
8
54
6
36
1.69
0.57
1.8
2.3
9.40
8.75
kpa
—
6
36
6
36
1.69
0.57
1.8
2.3
5.25
4.99
kpa
—
6
36
6
36
1.69
0.57
1.8
2.3
2.10
2.02
mmol/l
—
6
20
12
82
1.49
0.55
1.2
1.2
—
—
—
0
0
6
40
1.51
0.52
2.7
5.1
—
—
—
0
0
27
217
1.28
0.51
7.5
13.7
11.46
12.71
kpa
1.23
27
210
27
217
1.28
0.51
7.5
13.7
5.13
5.07
kpa
0.16
27
209
198
1926
1.32
0.50
18.2
12.4
—
—
—
0
0
17
128
1.36
0.49
1.3
1.5
0.91
1.29
g/l
0.88
17
117
27
219
1.27
0.48
7.4
13.8
7.42
7.41
ph
0.34
22
121
5
82
0.60
0.46
1.4
1.6
—
—
—
0
0
29
241
1.23
0.43
1.9
1.5
—
—
—
0
0
20
159
1.28
0.42
4.4
5.1
0.00
0.23
%
—
7
47
0
16
0.00
0.41
0.0
8.4
—
9.38
—
0
16
0
16
0.00
0.41
0.0
4.2
—
44.44
—
0
16
8
61
1.32
0.40
5.1
11.7
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
270.86
—
0
14
8
111
0.71
0.38
1.4
1.2
—
—
—
0
0
14
108
1.32
0.36
3.1
3.2
23.91
24.27
mmol/l
0.27
14
108
21
172
1.24
0.36
4.3
5.0
0.75
1.18
%
—
8
60
20
164
1.24
0.34
4.5
4.8
0.13
0.79
%
—
8
54
20
165
1.23
0.32
4.7
5.4
0.00
0.02
%
—
8
44
26
221
1.20
0.32
1.3
1.4
—
—
—
0
0
76
818
0.89
0.32
1.8
1.9
1.66
1.47
mmol/l
0.72
64
708
32
279
1.17
0.31
1.8
1.8
—
—
—
0
0
102
963
1.11
0.30
6.8
6.8
1.88
1.93
e9/l
0.24
94
864
97
1027
0.90
0.30
4.7
4.3
2.07
2.00
ug/l
0.05
90
932
179
1744
1.15
0.29
5.7
4.7
6.33
6.00
mmol/l
2.18
174
1628
184
1878
0.87
0.27
5.3
4.8
1.26
1.32
mmol/l
1.49
178
1775
11
138
0.79
0.26
1.9
1.3
219.79
369.86
u/ml
0.44
11
129
92
872
1.10
0.24
7.2
6.9
0.65
0.70
%
0.54
85
832
150
1454
1.10
0.24
4.1
3.6
52.45
52.51
u/l
0.00
144
1398
56
604
0.90
0.24
2.5
1.9
—
—
—
0
0
178
1741
1.12
0.23
8.7
5.9
40.98
39.41
mmol/mol
1.30
171
1663
22
192
1.16
0.21
2.8
2.9
1.79
1.91
%
0.24
22
177
0
10
0.00
0.21
0.0
2.0
—
4.16
—
0
10
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
3.00
—
0
10
0
10
0.00
0.21
0.0
2.0
—
2.10
—
0
10
0
12
0.00
0.21
0.0
1.3
—
0.53
—
0
6
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
1.76
—
0
13
0
13
0.00
0.21
0.0
1.0
—
0.33
—
0
5
22
193
1.16
0.20
2.5
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
6
52
1.16
0.19
4.2
3.4
69.18
66.04
%
—
6
52
26
289
0.89
0.18
1.5
1.5
—
—
—
0
0
7
61
1.15
0.17
4.7
3.3
—
—
—
0
0
22
196
1.14
0.17
8.7
14.5
127.82
125.34
g/l
0.17
22
191
101
974
1.07
0.16
6.8
7.2
0.22
0.20
e9/l
0.37
89
871
91
875
1.07
0.16
7.1
6.8
2.74
2.92
%
0.38
86
837
16
140
1.15
0.15
2.0
1.7
0.24
0.38
mg/l
—
8
63
91
877
1.06
0.14
7.2
6.9
8.65
8.92
%
0.48
86
841
11
95
1.17
0.12
1.4
1.2
—
—
—
0
0
178
1802
0.93
0.11
4.6
4.1
1.62
1.39
mmol/l
1.77
170
1691
188
1899
0.93
0.10
5.8
5.4
2.70
2.77
mmol/l
0.51
179
1798
21
193
1.10
0.10
1.1
1.2
—
—
—
0
0
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
6
54
1.11
0.09
1.3
1.1
—
—
—
0
0
29
273
1.07
0.08
1.3
1.3
1.01
6.61
u/ml
—
8
107
60
621
0.95
0.08
7.9
6.7
—
—
—
0
0
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
5
65
0.76
0.08
1.4
1.2
—
—
—
0
0
7
64
1.10
0.08
1.0
1.2
—
—
—
0
0
14
127
1.11
0.08
1.1
1.3
—
—
—
0
0
8
77
1.04
0.07
1.0
1.1
—
—
—
0
0
42
437
0.95
0.07
2.1
2.0
—
—
—
0
0
9
88
1.02
0.07
1.8
1.5
—
—
—
0
0
30
315
0.94
0.06
1.9
1.7
—
—
—
0
0
131
1292
1.04
0.06
3.8
3.6
14.72
14.64
pmol/l
0.13
123
1188
31
298
1.05
0.04
1.4
1.3
16.60
26.75
iu/ml
—
7
83
46
447
1.04
0.04
4.1
5.2
—
—
—
0
0
96
946
1.03
0.04
6.9
6.7
0.62
0.59
e9/l
0.75
84
824
96
948
1.02
0.03
7.0
6.8
0.05
0.04
e9/l
0.42
85
827
162
1610
1.02
0.02
4.6
4.4
1.76
1.88
mu/l
0.65
155
1510
27
262
1.03
0.02
1.3
1.4
217.14
367.27
titre
—
7
44
12
119
1.01
0.00
10.6
17.8
16.86
16.37
%
0.18
12
114
16
157
1.02
0.00
1.1
1.2
—
—
—
0
0
12
117
1.03
0.00
1.0
1.1
0.88
0.96
g/l
0.71
12
117
26
255
1.02
0.00
1.5
1.5
—
—
—
0
0
12
115
1.05
0.00
1.0
1.1
1.28
1.46
g/l
1.89
12
115
13
125
1.04
0.00
5.5
12.2
24.51
24.66
mmol/l
0.07
13
125
6
66
0.91
-0.00
1.8
1.6
—
5.49
—
0
15
0
6
0.00
-0.00
0.0
4.2
—
9.50
—
0
6
6
67
0.89
-0.00
1.2
2.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
57.60
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
2.02
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
9161.67
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
176.50
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
26.81
—
0
6
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
0.48
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
0.00
—
0
7
0
8
0.00
-0.00
0.0
2.1
—
17.88
—
0
8
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
35.14
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.4
—
28.86
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_OCCUPANT_HEAVY_TRANSPO_VEHIC_INJURED_OTHER_UNSPE_TRANSPO_ACCIDENTS – Occupant of heavy transport vehicle injured in other and unspecified transport accidents

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).